Officer sold ~$364K of Vertex Pharmaceuticals
Scheduled in advanceLoading…
Traded May 4, 2026 · Filed May 5, 2026
A board member of Vertex Pharmaceuticals sold $135K of Vertex Pharmaceuticals shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$134,746
Shares × reported transaction price
on the day of results (May 4, 2026), 91 days before results of Aug 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $429.85 on May 4, 2026, 17% above its 52-week low and 14% below its high, after a 5% drop over the previous 30 trading days
52-week range $366.54 (Aug 8, 2025) to $500.19 (May 5, 2025), 47% of the way up, from 251 adjusted closes. 30 trading days earlier: $454.00 on Mar 20, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.9% | +1.2% | +4.8% |
| 30 days | +4.5% | +0.5% | +4.0% |
| 90 days | +11.9% | +5.1% | +6.8% |
Past results only. Not a forecast.
Officer sold ~$364K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$888K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$15K of Vertex Pharmaceuticals
Scheduled in advance